Invesco Gl.Health Care Innov.Fd.Z AD USD
LU1775952333
Invesco Gl.Health Care Innov.Fd.Z AD USD/ LU1775952333 /
NAV18/10/2024 |
Chg.-0.1300 |
Type de rendement |
Focus sur l'investissement |
Société de fonds |
23.7300USD |
-0.54% |
paying dividend |
Equity
Worldwide
|
Invesco Management ▶ |
Stratégie d'investissement
The objective of the Fund is to achieve long-term capital growth. The Fund will invest primarily in shares of innovative healthcare companies worldwide.
For the purpose of the Fund, healthcare companies include (but are not limited to), pharmaceuticals, biotechnology, healthcare services and medical technology and supplies. The Fund seeks to invest in companies that have the potential to materially improve the quality of care, access to care or cost of care through their innovative approach to products and services, use of technology, processes and business models, or management. The Fund may use securities lending for efficient portfolio management purposes. The Fund may use derivatives (complex instruments) to manage the Fund more efficiently, with the aim of reducing risk, reducing costs and/or generating additional capital or income. The Fund is actively managed and is not constrained by its benchmark, MSCI World Health Care Index (Net Total Return), which is used for comparison purposes. However, the majority of the Fund's holdings are likely to be components of the benchmark. As an actively managed fund, this overlap will change continuously and this statement may be updated from time to time.
Objectif d'investissement
The objective of the Fund is to achieve long-term capital growth. The Fund will invest primarily in shares of innovative healthcare companies worldwide.
Opérations
Type de rendement: |
paying dividend |
Fonds Catégorie: |
Equity |
Région de placement: |
Worldwide |
Branche: |
Sector Health / Pharma |
Benchmark: |
MSCI World Health Care ND |
Début de l'exercice: |
29/02 |
Dernière distribution: |
- |
Banque dépositaire: |
The Bank of New York Mellon SA/NV |
Domicile: |
Luxembourg |
Permission de distribution: |
Austria, Germany, Switzerland, Luxembourg, Czech Republic |
Gestionnaire du fonds: |
Justin Livengood |
Actif net: |
305.71 Mio.
USD
|
Date de lancement: |
10/09/2018 |
Focus de l'investissement: |
- |
Conditions
Surtaxe d'émission: |
5.00% |
Frais d'administration max.: |
0.75% |
Investissement minimum: |
1,500.00 USD |
Deposit fees: |
0.01% |
Frais de rachat: |
0.00% |
Prospectus simplifié: |
Télécharger (Version imprimée) |
Société de fonds
Société de fonds: |
Invesco Management |
Adresse: |
An der Welle 5, 60322, Frankfurt am Main |
Pays: |
Germany |
Internet: |
www.de.invesco.com
|
Actifs
Stocks |
|
98.03% |
Mutual Funds |
|
1.90% |
Autres |
|
0.07% |
Pays
United States of America |
|
86.75% |
United Kingdom |
|
3.82% |
Denmark |
|
2.39% |
Ireland |
|
2.12% |
Switzerland |
|
1.70% |
Netherlands |
|
1.09% |
Australia |
|
0.16% |
Autres |
|
1.97% |
Branches
Pharma/Biotechnology |
|
45.14% |
Healthcare services |
|
30.62% |
Healthcare appliances |
|
19.16% |
Parma, wholesale |
|
1.56% |
Healthcare |
|
1.26% |
Gesundheitswesen/ Informationstechnologie |
|
0.30% |
Autres |
|
1.96% |